STOCK TITAN

Investors Title Co Nc Form 4 Filings

ITIC NASDAQ

Every Form 4 that Investors Title Co Nc (ITIC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ITIC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ITIC filings page.

Rhea-AI Summary

INVESTORS TITLE CO (ITIC) director Tammy Coley reported only acquisition-type transactions on August 27, 2026. She exercised three tranches of Stock Appreciation Rights covering a total of 363 shares of common stock, with exercise prices of $160.94, $246.75, and $238.06 per share, and received matching grants of 363 common shares. No sales or dispositions were reported in this filing.

Rhea-AI Summary

Investors Title Co director Richard M. Hutson II reported a grant or award of 212 shares of Common Stock on 2026-08-12 at a value of $122.80 per share. Following this compensation-related acquisition, his directly held position increased to 4,898 shares of Investors Title Co common stock.

Rhea-AI Summary

Investors Title Co director Tammy Coley received a grant of 750 Stock Appreciation Rights tied to an equal number of common shares. The rights have an exercise price of $238.06 per share, become exercisable on June 30, 2026, and expire on May 20, 2033. This is a compensation-related award, not an open-market stock purchase or sale.

Rhea-AI Summary

INVESTORS TITLE CO director receives stock-based award. Director Joseph B. Dempster Jr. was granted 750 Stock Appreciation Rights on May 20, 2026. Each right is tied to one share of common stock with a conversion price of $238.06 per share and expires on May 20, 2033.

Rhea-AI Summary

Hutson Richard M II reported acquisition or exercise transactions in this Form 4 filing.

Investors Title Co director Richard M. Hutson II received a grant of stock-based compensation. On May 20, 2026, he was awarded 750 Stock Appreciation Rights, each tied to one share of common stock with a base price of $238.06. These rights become exercisable on June 30, 2026 and expire on May 20, 2033. This is a compensation award, not an open-market stock purchase or sale.

Rhea-AI Summary

Investors Title Co director Elton C. Parker Jr. received a grant of Stock Appreciation Rights tied to the company’s common stock. The award covers 750 underlying shares at an exercise price of $238.06 per share and is scheduled to expire on May 20, 2033. This is a compensation-related, non-market transaction with no open-market buying or selling reported.

Rhea-AI Summary

Investors Title Co director James E. Scott received a grant of 750 Stock Appreciation Rights on May 20, 2026. Each right is tied to one share of common stock with an exercise price of $238.06, first exercisable on June 30, 2026, and expiring on May 20, 2033.

Rhea-AI Summary

Investors Title Co director James H. Speed Jr. received a grant of 750 stock appreciation rights tied to the company’s common stock. These rights have an exercise price of $238.06 per share and are scheduled to become exercisable on June 30, 2026, expiring on May 20, 2033.

This is a compensation-related award rather than an open-market trade, so it does not reflect a buy or sell decision in the company’s stock.

Rhea-AI Summary

INVESTORS TITLE CO director Elton C. Parker Jr. reported an open-market purchase of common stock. He bought 538 shares of Common Stock at a price of $231.00 per share. Following this transaction, his direct holdings increased to 3,750 shares of the company’s common stock.

Rhea-AI Summary

Investors Title Company director James H. Speed Jr. exercised stock appreciation rights for 210 shares of common stock at $162.81 per share equivalent and received 210 shares as an award. Following these compensation-related acquisitions, he directly holds 2,987 shares of Investors Title common stock.

Rhea-AI Summary

Investors Title Company director Elton C. Parker Jr. reported compensation-related equity activity. He exercised stock appreciation rights covering 212 shares of common stock at an exercise price of $162.29 per share, and received 212 shares of common stock. Following these transactions, he directly holds 3,212 common shares, reflecting an increase in his equity stake through awards rather than open-market purchases.

Rhea-AI Summary

Investors Title Company director James E. Scott reported an open-market purchase of common stock. On February 20, 2026, he bought 500 shares at an average price of $220.7107 per share, increasing his direct ownership to a total of 600 shares of Investors Title common stock.